O'Heeron Pete's Form 4 filing
FibroBiologics, Inc. (FBLG) · filed Mar 4, 2026
- Accession no.
- 0001493152-26-008903
- Filed
- Mar 4, 2026, 5:50 PM ET
- Trade date
- Mar 2-4, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market purchases total $19.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| O'Heeron PeteCIK 0001569334 | Director, Officer (CHIEF EXECUTIVE OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | Common Stock | PPurchaseAcquired | +17,428 | $0.353F1 | +$6,152.08 | 5,924,075 | Direct | |
| Mar 3, 2026 | Common Stock | PPurchaseAcquired | +18,200 | $0.4051F1 | +$7,372.82 | 5,942,275 | Direct | |
| Mar 4, 2026 | Common Stock | PPurchaseAcquired | +15,872 | $0.3784F1 | +$6,005.96 | 5,958,147 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $0.3210 to $0.4166 on March 2, 2026, $0.3885 to $0.4302 on March 3, 2026, and $0.3730 to $0.3820 on March 4, 2026. The reporting person will provide upon request to the SEC, the Issuer, or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
Referenced by the price of 3 transactions in Table I.